10x Genomics, Inc.
TXG
$10.61
-$1.09-9.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -37.13% | 5.66% | 36.78% | -22.46% | 47.36% |
| Total Depreciation and Amortization | -1.73% | -1.38% | -5.17% | -1.81% | 2.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.66% | -12.72% | -1.20% | -15.04% | 14.58% |
| Change in Net Operating Assets | -110.59% | 419.61% | 35.45% | -136.90% | 5.54% |
| Cash from Operations | -131.18% | 188.70% | 147.67% | -161.05% | 201.79% |
| Capital Expenditure | 30.16% | -35.13% | 1.10% | 15.65% | 77.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18,135.42% | -98.17% | 9.47% | -18.17% | -17.82% |
| Cash from Investing | -1,325.98% | -130.28% | 12.37% | -18.83% | 167.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,795.51% | -96.61% | 181.01% | -70.82% | 28.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,795.51% | -96.61% | 181.01% | -70.82% | 28.33% |
| Foreign Exchange rate Adjustments | -272.44% | 5,300.00% | 93.75% | -162.34% | 190.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -395.02% | -23.74% | 786.35% | -107.86% | 376.43% |
